GBM39 GBM Model
GBM39, a Patient-Derived Xenograft (PDX) model, is your partner in unraveling brain cancer mysteries. Use GBM39 to explore disease mechanisms and develop novel therapies for this challenging condition. PDX models like GBM39 play a pivotal role in preclinical drug discovery. By faithfully replicating the patient's tumor, GBM39 enables researchers to identify and
Model Details
Cancer Location: Intracranial
Cancer Type: Brain Cancer
Model Name: GBM39
Mouse Strain: Nu/Nu
Treatment Data Available: Chemotherapy (Temozolomide)
WES: Yes
RNAseq: Yes
Methylation: Yes
EGFR Exon Varient: EGFRvIII
PDX Treatment: Yes
Patient Treatment History: Yes
GBM39 Survival
Survival of orthotopic intracranial implanted GBM39 in Nu/Nu mice (n=10)
